Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Grace Therapeutics (GRCE US)
Watchlist
3
Analysis
Health Care
•
United States
Grace Therapeutics, Inc. operates as a late-stage biopharma company. The Company focuses on drug delivery and technologies addressing rare and orphan diseases. Grace Therapeutics serves clients in Canada and the United States.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Grace Therapeutics
•
18 Nov 2024 23:00
•
Issuer-paid
GRCE: FY:25 Second Quarter Results
Grace is a clinical-stage, biotechnology company focused on rare disease. Its lead program, GTX-104, is a novel injectable formulation of...
Zacks Small Cap Research
Follow
124 Views
Share
bullish
•
Grace Therapeutics
•
05 Nov 2024 11:22
•
Issuer-paid
Grace Therapeutics, Inc: Initiating Coverage – From Confusion to Infusion
Grace is a clinical-stage, biotechnology company focused on rare disease.Its lead program is for GTX-104, a novel injectable formulation of...
Zacks Small Cap Research
Follow
125 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x